ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Aelis Farma SA

Aelis Farma SA (AELIS)

2.66
-0.02
(-0.75%)
Closed December 03 11:30AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
2.66
Bid
2.62
Ask
2.68
Volume
2,090
2.50 Day's Range 2.76
2.50 52 Week Range 13.60
Market Cap
Previous Close
2.68
Open
2.64
Last Trade
50
@
2.66
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
1,035
Shares Outstanding
13,257,762
Dividend Yield
-
PE Ratio
-6.95
Earnings Per Share (EPS)
-0.38
Revenue
12.36M
Net Profit
-5.08M

About Aelis Farma SA

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Headquarters
Bordeaux, Gironde, Fra
Founded
-
Aelis Farma SA is listed in the Coml Physical, Biologcl Resh sector of the Euronext with ticker AELIS. The last closing price for Aelis Farma was 2.68 €. Over the last year, Aelis Farma shares have traded in a share price range of 2.50 € to 13.60 €.

Aelis Farma currently has 13,257,762 shares outstanding. The market capitalization of Aelis Farma is 35.53 € million. Aelis Farma has a price to earnings ratio (PE ratio) of -6.95.

AELIS Latest News

Aelis Farma : Apport complémentaire au contrat de liquidité conclu avec Invest Securities

Regulatory News: Aelis Farma (ISIN : FR0014007ZB4 – Mnémonique : AELIS, éligible PEA-PME), société biopharmaceutique au stade clinique spécialisée dans le développement de traitements pour les...

Aelis Farma annonce les résultats positifs de son étude clinique de phase 1/2 avec AEF0217 chez de jeunes adultes avec une trisomie 21

Le CB1-SSi AEF0217 a atteint avec succès les objectifs en matière de sécurité (critère principal), de pharmacocinétique (critère secondaire) et d’efficacité (critères secondaires et...

Aelis Farma : Mise à disposition du rapport financier semestriel 2024

Regulatory News: Aelis Farma (ISIN : FR0014007ZB4 – Mnémonique : AELIS, éligible PEA-PME), société biopharmaceutique au stade clinique spécialisée dans le développement de traitements pour les...

Aelis Farma Announces Half-year Financial Results for 2024 and Provides Corporate and Development Update

A solid cash position of €12.6 million at June 30, 2024, not including the gross amount of €4.5 million share offering which occurred at the end of July and other non-dilutive financing...

Aelis Farma annonce les résultats de son étude clinique de phase 2B avec AEF0117 chez des participants souffrant de troubles liés à l'usage excessif de cannabis (CUD)

L’objectif principal de cette étude de phase 2B était de démontrer que AEF0117 réduit la consommation de cannabis et de déterminer les critères d’évaluation et les doses optimales à utiliser...

Aelis Farma : Apport complémentaire au contrat de liquidité conclu avec Invest Securities

Regulatory News: Aelis Farma (ISIN : FR0014007ZB4 – Mnémonique : AELIS, éligible PEA-PME), société biopharmaceutique au stade clinique spécialisée dans le développement de traitements pour les...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.2-6.993006993012.862.92.527442.6986697DE
4-0.82-23.56321839083.483.682.519372.84062454DE
12-3.14-54.13793103455.85.82.510353.43428445DE
26-10.54-79.848484848513.213.22.57485.7786783DE
52-10.74-80.149253731313.413.62.55287.86812823DE
156-10.84-80.296296296313.514.482.564711.36545977DE
260-10.84-80.296296296313.514.482.564711.36545977DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALCYBCybergun
0.0002 €
(100.00%)
10.06M
ALVETEGEIRO Pharma
0.124 €
(58.97%)
481.8k
ALDVAlliance Developpement Capital Siic
0.074 €
(32.14%)
6k
MLSRPSpeed Rabbit Pizza
8.20 €
(30.16%)
19
MLSEQSequa Petroleum NV
0.011 €
(29.41%)
12k
MLCOTCoretech 5
0.01 €
(-41.18%)
200
ATOAtos SE
0.495 €
(-32.65%)
17.92M
AFMEAffluent Medical
1.20 €
(-21.05%)
21.92k
ALBIOBiosynex
2.095 €
(-18.32%)
26.9k
TRACTTeract SA
1.03 €
(-15.23%)
76.91k
BCPBanco Comercial Portugues SA
0.4457 €
(2.20%)
44.64M
ALNEVNeovacs
0.0003 €
(0.00%)
33.59M
ATOAtos SE
0.495 €
(-32.65%)
17.92M
ALCYBCybergun
0.0002 €
(100.00%)
10.06M
ORAOrange.
9.706 €
(-2.99%)
9.65M

Discussion

View Full Feed
RickNagra RickNagra 3 minutes ago
Sure wish DT Junior would join our board and send us 160% soaring.  {insert long drawn out sigh}.
FNMA
linkvest linkvest 3 minutes ago
9s are the GOLDEN SHARES to have but the 1s taste just as good when RDAR is sitting at .01......
RDAR
SPANISH_gladiator SPANISH_gladiator 3 minutes ago
whithout falling in delincuency
RMTD
fink fink 3 minutes ago
Don't forget the O/S hasn't changed in a year.

My focus is on buying any dips and Audited. Screw the day to day. The price can go either way for all I care.
IGPK
fink fink 3 minutes ago
Don't forget the O/S hasn't changed in a year.

My focus is on buying any dips and Audited. Screw the day to day. The price can go either way for all I care.
IGPK
FinnMcMissile FinnMcMissile 3 minutes ago
You're usually great at dumbing this stuff down for me....Need a nomo explanation
HMBL
wadegarret wadegarret 3 minutes ago
R59- SMCI

From my understanding SMCI's in house auditors have found nothing wrong with the way SMCI has reported numbers. So now we're all waiting for BDO's formal independent opinion- is that right ? Re, assuming BDO finds nothing wrong, and SMCI makes their $3.75 eps in 2025,
SMCI
Nrdc92 Nrdc92 4 minutes ago
It's not "difficult to understand."  What is difficult to understand is why, if you have a financial stake in success, you tow the company line repeatedly without an ounce of pushback despite the company repeatedly diluting your financial stake, failing to execute, and delivering nothing of value. 
LWLG
al44 al44 4 minutes ago
A hopeful at FBI-

https://media.gettr.com/group4/getter/2024/12/03/16/417f3c92-a550-cf29-ecdb-02dcc84e6c01/1492e880d659d666cf4fb5867ec0d86b_768x0.jpg
Lone Clone Lone Clone 4 minutes ago
American Eagle Expands North Zone High-Grade Mineralization

American Eagle's North Zone Highlights:

NAK24-27 intercepted 50 m of 1.01% Copper Equivalent (CuEq)

within 252 m of 0.48% CuEq

within 600 m of 0.33% CuEq
al44 al44 4 minutes ago
A hopeful at FBI-

https://media.gettr.com/group4/getter/2024/12/03/16/417f3c92-a550-cf29-ecdb-02dcc84e6c01/1492e880d659d666cf4fb5867ec0d86b_768x0.jpg
Makemone1 Makemone1 4 minutes ago
Now at trip 000's . Great stock huh lol total garbage
INKW
goodietime goodietime 4 minutes ago
"COOP @ $120+ in February 2025 IMO"

So, iyo, is the BOD failing its fiduciary responsibility by NOT buying back shares at this 'bargain price'?
COOP
mike papa mike papa 4 minutes ago
UDHI since 2006.
XCRT
JustGoDeep JustGoDeep 4 minutes ago
Work It For Me I Just Put In

An Order For Many More Shares!!


WORK IT!! LMAO
BIEL
joe botts joe botts 4 minutes ago
Wow how'd ya know??.
Peace1965 Peace1965 4 minutes ago
Cowboy 🤠 hat.. You don’t feel ashamed of yourself for your lying day after day here and INQD post..? I dare you post on X board .. oh I forgot, you get pay by post..
INQD
Golden Cross Golden Cross 4 minutes ago
$ILLR AI technology has been a Game Changer for triller. Major
developments are happening at Triller! Way Undervalued Here!

https://www.youtube.com/watch?v=trYbvzzlWSc

[yt]trYbvzzlWSc[/yt]
ILLR
billydburger billydburger 5 minutes ago
A billion shares... at 0.0000000001 on a revoked stock
SPARK SPARK 5 minutes ago
HSAI 8.25~
HSAI
linkvest linkvest 5 minutes ago
LOL.. 10m always looks nice in the portfolio... Love to see this Beast up a few ticks now.
RDAR
katiesdad7 katiesdad7 5 minutes ago
So what did the project manager tell you?
CBRF
tapioca tapioca 5 minutes ago
Looks like it will land just under $9, if the pps holds here in mid 20’s. I’m tempted to buy more since I’m slightly red now, but I just don’t trust anything this company does, particularly with this r/s. I agree there could be a short attack if there isn’t huge news and volume attached to this spl
RNAZ
nyt nyt 5 minutes ago
52 week lows are quite significant as well, even for the likes of Vplm. Can't help wondering if it's getting beyond the control of the MMs, in terms of what they can get away with......although, it kind of seems like Vplm is allowed to get away with whatever they want, regardless. One need only to l
VPLM